COMPUGEN LTD (CGEN) Fundamental Analysis & Valuation

NASDAQ:CGEN • IL0010852080

Current stock price

2.09 USD
-0.02 (-0.95%)
Last:

This CGEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CGEN Profitability Analysis

1.1 Basic Checks

  • In the past year CGEN was profitable.
  • In the past year CGEN has reported a negative cash flow from operations.
  • CGEN had negative earnings in each of the past 5 years.
  • In the past 5 years CGEN reported 4 times negative operating cash flow.
CGEN Yearly Net Income VS EBIT VS OCF VS FCFCGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • CGEN has a better Return On Assets (-18.17%) than 76.98% of its industry peers.
  • The Return On Equity of CGEN (-38.52%) is better than 69.83% of its industry peers.
Industry RankSector Rank
ROA -18.17%
ROE -38.52%
ROIC N/A
ROA(3y)-21.2%
ROA(5y)-22.19%
ROE(3y)-32.63%
ROE(5y)-30.94%
ROIC(3y)N/A
ROIC(5y)N/A
CGEN Yearly ROA, ROE, ROICCGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • CGEN has a better Gross Margin (62.33%) than 78.53% of its industry peers.
  • CGEN's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CGEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.9%
GM growth 5YN/A
CGEN Yearly Profit, Operating, Gross MarginsCGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CGEN Health Analysis

2.1 Basic Checks

  • CGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for CGEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CGEN Yearly Shares OutstandingCGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CGEN Yearly Total Debt VS Total AssetsCGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -4.05, we must say that CGEN is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CGEN (-4.05) is comparable to the rest of the industry.
  • CGEN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.05
ROIC/WACCN/A
WACC8.58%
CGEN Yearly LT Debt VS Equity VS FCFCGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 4.74 indicates that CGEN has no problem at all paying its short term obligations.
  • With a Current ratio value of 4.74, CGEN perfoms like the industry average, outperforming 54.35% of the companies in the same industry.
  • CGEN has a Quick Ratio of 4.74. This indicates that CGEN is financially healthy and has no problem in meeting its short term obligations.
  • CGEN has a Quick ratio of 4.74. This is comparable to the rest of the industry: CGEN outperforms 55.71% of its industry peers.
Industry RankSector Rank
Current Ratio 4.74
Quick Ratio 4.74
CGEN Yearly Current Assets VS Current LiabilitesCGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CGEN Growth Analysis

3.1 Past

  • CGEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 331.25%, which is quite impressive.
EPS 1Y (TTM)331.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%957.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4477.29%

3.2 Future

  • The Earnings Per Share is expected to decrease by -15.80% on average over the next years. This is quite bad
  • Based on estimates for the next years, CGEN will show a very strong growth in Revenue. The Revenue will grow by 50.25% on average per year.
EPS Next Y-158.99%
EPS Next 2Y-56.59%
EPS Next 3Y-45.42%
EPS Next 5Y-15.8%
Revenue Next Year164.92%
Revenue Next 2Y104.96%
Revenue Next 3Y71.33%
Revenue Next 5Y50.25%

3.3 Evolution

CGEN Yearly Revenue VS EstimatesCGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 20M 40M 60M 80M
CGEN Yearly EPS VS EstimatesCGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. CGEN Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 5.65, the valuation of CGEN can be described as very cheap.
  • Based on the Price/Earnings ratio, CGEN is valued cheaply inside the industry as 98.07% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of CGEN to the average of the S&P500 Index (25.23), we can say CGEN is valued rather cheaply.
  • CGEN is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 5.65
Fwd PE N/A
CGEN Price Earnings VS Forward Price EarningsCGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGEN Per share dataCGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • CGEN's earnings are expected to decrease with -45.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-56.59%
EPS Next 3Y-45.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CGEN Dividend Analysis

5.1 Amount

  • CGEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CGEN Fundamentals: All Metrics, Ratios and Statistics

COMPUGEN LTD

NASDAQ:CGEN (3/20/2026, 8:00:00 PM)

2.09

-0.02 (-0.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-02
Earnings (Next)05-18
Inst Owners13.61%
Inst Owner Change0.72%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap195.50M
Revenue(TTM)N/A
Net Income(TTM)-19.36M
Analysts87.27
Price Target6.38 (205.26%)
Short Float %1.16%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.63%
Min EPS beat(2)-42.6%
Max EPS beat(2)-20.66%
EPS beat(4)0
Avg EPS beat(4)-86.89%
Min EPS beat(4)-193.59%
Max EPS beat(4)-20.66%
EPS beat(8)1
Avg EPS beat(8)-75.17%
EPS beat(12)4
Avg EPS beat(12)-42.88%
EPS beat(16)8
Avg EPS beat(16)-26.17%
Revenue beat(2)0
Avg Revenue beat(2)-54.18%
Min Revenue beat(2)-68.82%
Max Revenue beat(2)-39.54%
Revenue beat(4)0
Avg Revenue beat(4)-51.51%
Min Revenue beat(4)-91.73%
Max Revenue beat(4)-5.97%
Revenue beat(8)2
Avg Revenue beat(8)-17.25%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)44.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.65
Fwd PE N/A
P/S 8.83
P/FCF N/A
P/OCF N/A
P/B 3.89
P/tB 3.89
EV/EBITDA N/A
EPS(TTM)0.37
EY17.7%
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.24
BVpS0.54
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.11
Profitability
Industry RankSector Rank
ROA -18.17%
ROE -38.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.33%
FCFM N/A
ROA(3y)-21.2%
ROA(5y)-22.19%
ROE(3y)-32.63%
ROE(5y)-30.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.9%
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 64.03%
Cap/Sales 1.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.74
Quick Ratio 4.74
Altman-Z -4.05
F-Score3
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)54.17%
Cap/Depr(5y)49.83%
Cap/Sales(3y)2.49%
Cap/Sales(5y)4.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)331.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%957.14%
EPS Next Y-158.99%
EPS Next 2Y-56.59%
EPS Next 3Y-45.42%
EPS Next 5Y-15.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4477.29%
Revenue Next Year164.92%
Revenue Next 2Y104.96%
Revenue Next 3Y71.33%
Revenue Next 5Y50.25%
EBIT growth 1Y-335.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y72.39%
OCF growth 3YN/A
OCF growth 5YN/A

COMPUGEN LTD / CGEN Fundamental Analysis FAQ

What is the fundamental rating for CGEN stock?

ChartMill assigns a fundamental rating of 3 / 10 to CGEN.


What is the valuation status for CGEN stock?

ChartMill assigns a valuation rating of 2 / 10 to COMPUGEN LTD (CGEN). This can be considered as Overvalued.


What is the profitability of CGEN stock?

COMPUGEN LTD (CGEN) has a profitability rating of 2 / 10.


What is the earnings growth outlook for COMPUGEN LTD?

The Earnings per Share (EPS) of COMPUGEN LTD (CGEN) is expected to decline by -158.99% in the next year.